11Writing prescriptions—when pharmaceutical benefits are the same

#### 11 Writing prescriptions—when pharmaceutical benefits are the same For the purposes of the application of paragraph 40(3)(a) of the National Health (Pharmaceutical Benefits) Regulations 2017 to a prescription for the special arrangement supply of a botulinum toxin pharmaceutical benefit, a botulinum toxin pharmaceutical benefit is taken to be the same as a botulinum toxin pharmaceutical benefit for which the PBS prescriber has written, on the same day, another prescription only if: (a) the prescriptions for the supply of both benefits are written in relation to the treatment of: (i) moderate to severe spasticity of the upper limb (whether or not following an acute event); or (ii) moderate to severe spasticity of the lower limb following an acute event; or (iii) urinary incontinence; or (iv) spasmodic torticollis; or (v) dynamic equinus foot deformity; or (vi) blepharospasm; or (vii) hemifacial spasm; or (viii) chronic migraine; or (ix) severe primary axillary hyperhidrosis; or (x) chronic sialorrhea; or (b) the prescriptions for the supply of both benefits are written in circumstances, determined by the Minister under paragraph 85(7)(b) of the Act, that have the same circumstances code (within the meaning of the Listing Instrument).